Parkinson Disease
📧 Sign up to get email alerts when something new happens for Parkinson Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: Virtual Reality Verses Conventional Physical Therapy in Parkinson's Disease Patients [NA]
A clinical trial is evaluating virtual reality therapy versus conventional physical therapy in Parkinson's disease patients, and the study i…
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: Parkin Mutations and Their Functional Consequences
This clinical trial update reports on Parkin gene mutations and their functional consequences in Parkinson's disease.
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: Early Detection of Selected Neuropathologies in Motor Vehicle Drivers
This clinical trial update describes an ongoing study led by University Hospital Olomouc to detect early markers of selected neuropathologie…
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: Myrosinase Bioactivated Gglucoraphanin for the Treatment of Neurodegenerative Diseases (GRA-MYR-ND) [NA]
This clinical trial update indicates that a study of myrosinase-activated glucoraphanin for neurodegenerative diseases is currently recruiti…
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: Subthalamic Nucleus (STN) Targeted Transcranial Temporal Interference Stimulation (TIS) Treats Parkinson's Disease [NA]
A clinical trial is investigating subthalamic nucleus targeted transcranial temporal interference stimulation as a treatment for Parkinson's…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: Fexofenadine as Adjuvant Therapy in Parkinson Disease [Phase 2, Phase 3]
A Phase 2/3 clinical trial evaluating fexofenadine as adjuvant therapy for Parkinson disease is currently recruiting, sponsored by Tanta Uni…
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: Attributional Style and Parkinson's Disease [NA]
The clinical trial NCT03371277 investigating attributional style in Parkinson's disease patients has completed, sponsored by CHU de Reims.
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: GYKO-Based L-Test Reliability in Parkinson's Disease
This update reports on ongoing clinical testing of the GYKO-based L-Test to assess reliability in Parkinson's disease, with the study curren…
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: Long Term Effectiveness of Levodopa-Entacapone-Carbidopa Intestinal Gel in Participants With Advanced Parkinson's Disease
A long-term clinical trial is evaluating the effectiveness of Levodopa-Entacapone-Carbidopa intestinal gel in people with advanced Parkinson…
-
CLINICAL_TRIALS trial_result · 2026-01-21Clinical Trial Update: Voice-activated Intelligent Personal Assistant (VIPA) Intervention for People With Parkinson's Disease [NA]
A completed clinical trial evaluated a voice-activated intelligent personal assistant (VIPA) intervention for people with Parkinson's diseas…
-
CLINICAL_TRIALS trial_result · 2026-01-20Clinical Trial Update: A Study to Evaluate the Safety of Neural Stem Cells in Patients With Parkinson's Disease [Phase 1]
A Phase 1 trial evaluating the safety of neural stem cells in Parkinson's disease has completed. The update summarizes safety outcomes from …
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: The Effect of Proprioceptive Neuromuscular Facilitation on Trunk Mobility, Gait, Fear of Falling, and Quality of Life in Individuals Diagnosed With Parkinson's Disease [NA]
This entry reports that Pamukkale University's clinical trial studying the effects of proprioceptive neuromuscular facilitation on trunk mob…
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: Comprehensive Assessment of Neurodegeneration and Dementia
Clinical trial at McGill University is actively recruiting to comprehensively assess neurodegeneration and dementia across multiple cognitiv…
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: Understanding How Movements Are Transferred From Task to Task in Parkinson's Disease [NA]
McGill University is conducting a Parkinson's disease study, currently recruiting, to understand how movements transfer between tasks.
-
CLINICAL_TRIALS trial_result · 2026-01-16Clinical Trial Update: Efficacy and Safety of TJ0113 Capsule in Patients With Parkinson's Disease [Phase 2]
Phase 2 trial evaluating the efficacy and safety of TJ0113 Capsule in Parkinson's disease has completed with results posted.
-
EMA approval · 2026-01-16EMA Authorised: Rivastigmine Hexal (rivastigmine) — Hexal AG
Hexal AG's rivastigmine product has been authorized in the EU for dementia-related indications including Alzheimer's disease and Parkinson's…
-
EMA approval · 2026-01-16EMA Authorised: Rivastigmine Sandoz (rivastigmine) — Sandoz GmbH
The European Medicines Agency authorised Rivastigmine Sandoz (rivastigmine) for dementia indications, including Alzheimer's disease and Park…
-
CLINICAL_TRIALS research · 2026-01-16Clinical Trial Update: Sensory Filtering in the Human Basal Ganglia as a Mechanism of Parkinson's Disease
A clinical trial investigating sensory filtering in the human basal ganglia as a mechanism of Parkinson disease is currently recruiting.
-
CLINICAL_TRIALS research · 2026-01-16Clinical Trial Update: Slowing Cognitive Decline in Alpha-synucleinopathies by Enhancing Physical Activity [NA]
This clinical trial update reports on a study aimed at slowing cognitive decline in alpha-synucleinopathies through enhanced physical activi…
-
CLINICAL_TRIALS research · 2026-01-16Clinical Trial Update: Automated Imaging Differentiation of Parkinsonism
University of Florida is conducting a clinical trial to assess automated imaging methods for differentiating parkinsonian syndromes, includi…
-
CLINICAL_TRIALS research · 2026-01-16Clinical Trial Update: Open-label Study to Evaluate Brain α-Synuclein Deposition Using PET and [18F]MK-0947 in Parkinson's Disease [EARLY_Phase 1]
An open-label early-phase study in Parkinson's disease assessing brain alpha-synuclein deposition via PET using the radiotracer [18F]MK-0947…
-
EMA approval · 2026-01-16EMA Authorised: Rivastigmine 1 A Pharma (rivastigmine) — 1 A Pharma GmbH
The EMA authorised rivastigmine from 1 A Pharma GmbH for use in Alzheimer's disease, dementia, and Parkinson's disease.
-
CLINICAL_TRIALS trial_result · 2026-01-15Clinical Trial Update: A Study of Suvecaltamide in Adults With Moderate to Severe Residual Tremor in Parkinson's Disease [Phase 2]
Phase 2 study of suvecaltamide in adults with residual tremor associated with Parkinson's disease has completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2026-01-15Clinical Trial Update: Safety and Efficacy Study of Parkinson's Disease Gene Therapy Drug (BBM-P002) [EARLY_Phase 1]
An early-phase safety and efficacy study of the Parkinson's disease gene therapy BBM-P002 has completed (Phase 1).
-
CLINICAL_TRIALS trial_result · 2026-01-15Clinical Trial Update: Cognitive Disparities in Parkinson's Disease
This update notes the completion of a clinical trial investigating cognitive disparities in Parkinson disease conducted by Duke University.